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Abstract
Nephrin is a critical component of glomerular filtration barrier, which is important to maintain
glomerular structure and avoid proteinuria. Downregulation of nephrin expression is com-
monly observed at early stage of glomerular disorders, suggesting that methods to increase
nephrin expression in podocytes may have therapeutic utility. Here, we generated a knockin
mouse line carrying single copy of 5.5 kb nephrin promoter controlling expression of
enhanced green fluorescent protein (EGFP) at Rosa26 genomic locus (Nephrin-EGFP
mouse). In these mice, EGFP was specifically expressed in podocytes. Next, we isolated
and cultivated glomeruli from these mice, and developed a protocol to automatically quanti-
tate EGFP expression in cultured glomeruli. EGFP signal was markedly reduced after 5
days of culture but reduction was inhibited by vitamin D treatment. We confirmed that vita-
min D increased mRNA and protein expression of endogenous nephrin in cultivated glomer-
uli. Thus, we generated a mouse line converting nephrin promoter activity into
fluorescence, which can be used to screen compounds having activity to enhance nephrin
gene expression.
Introduction
Slit membrane synthesized by podocytes plays an essential role to form glomerular filtration
barrier in the kidney [1]. Loss in the function and numbers of podocytes is a key event in vari-
ous renal disorders, leading to proteinuria, glomerulosclerosis and, eventually, end-stage renal
disease [2]. To alleviate podocyte injury is one of major strategies to treat chronic kidney dis-
ease, but still efficient treatment options are limited [3]. Nephrin is a critical component of glo-
merular filtration barrier [4]. Downregulation of nephrin expression is commonly observed at
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early stage of glomerular disorders [3, 5], suggesting that methods to increase nephrin expres-
sion in podocytes may have therapeutic utility.
Vitamin D has been known to increase nephrin expression in cultured mouse podocytes
[6]. In renal precursor cells derived from human kidney cortex [7] or human amnion [8], vita-
min D upregulates nephrin expression and induces differentiation into podocytes. Further-
more, recent reports have shown that vitamin D ameliorates proteinuria and glomerular
lesions in murine models of diabetic nephropathy [9, 10] or puromycin-induced nephrosis
[11]. These findings suggest that screening of compounds having activity to enhance nephrin
expression may lead to identification of a new therapeutic reagent to combat glomerular
disorders.
Screening chemicals using gene promoter activity as an index is often performed using cul-
tured cells transfected with a reporter plasmid encoding a fluorescent protein or an enzyme at
the downstream of promoter sequence. However, the copy numbers or genomic locations of
inserted gene cannot be controlled by gene transfer methods such as lipofection or electropora-
tion. Therefore, it is important to analyze several independent clones to verify reproducibility.
Transgenic (Tg) animals are quite useful to analyze a role of gene in vivo, but they also have the
same problems of Tg copy numbers and integration sites and also a concern about unexpected
disruption of unrelated gene. Indeed, introducing too much reporter DNA into cells may con-
sume up transcription factors, resulting in unphysiological responses. Therefore, to strictly
study developmental, spatio-temporal or pathophysiologic regulation of gene expression in
vivo, gene knockin method by homologous recombination has been used to insert reporter
gene under control of endogenous promoter [12], but these experiments are time consuming.
We invented a method to insert a single copy of DNA cassette, uni-directionally, into a spe-
cific genomic locus by direct injection of DNA construct into fertilized eggs utilizing the Cre-
loxP system-mediated gene arrangement. This method, termed pronuclear injection-based tar-
geted transgenesis (PITT), bypasses a use and screen of embryonic stem cells [13, 14], and can
markedly reduce potential interference from enhancer or silencer sequences surrounding the
inserted gene.
In this study, we report establishment of a mouse cell line expressing enhanced green fluo-
rescence protein (EGFP) under nephrin promoter using PITT method, and its use to screen
compounds with activity to enhance nephrin expression.
Materials and Methods
Chemicals and media
Chemical reagents and media were purchased from Nacalai Tesque (Kyoto, Japan) unless oth-
erwise described.
Generation of nephrin reporter mice using PITT method
Donor vector pBEJ, carrying nephrin promoter sequence, EGFP cDNA, polyA signal and FRT,
was generated as described previously [13–15]. Its insert was flanked with 2 loxP mutant
sequences, lox2272 and JTZ17, which allow directional gene recombination by Cre recombi-
nase (Fig 1). Cre expression plasmid (5 ng/μl) and pBEJ (10 ng/μl) were co-injected into pronu-
clei of fertilized eggs obtained from a seed mouse strain, Gt(ROSA)26Sortm1Maoh (also termed
as TOKMO-1) [13]. Seed mice carry mutant loxP sequences (lox2272 and JT15), neomycin
resistance gene cassette and flippase (FLP) recombinase target (FRT) sequence at intron 1 of
Rosa26 locus. FLPe Tg mice (RBRC01835, RIKEN BioResource Center, Ibaragi, Tsukuba,
Japan) were used to delete extra sequence containing neomycin cassette and vector sequence
flanked with FRT [16]. Functional analysis of the reporter mouse line was carried out after
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backcrossing to C57BL/6N mice (Charles River Laboratories Japan, Yokohama, Japan) for 3
generations.
Animal care and procedures were approved by Institutional Animal Care and Use Commit-
tees of Tokai University (permit numbers 121007, 132013) and Kyoto University Graduate
School of Medicine (Med Kyo 13116). Mice were maintained on a 12 hour light/dark cycle
with free access to standard diet (F-2, Oriental BioService, Kyoto, Japan) and water. All mice
were examined twice a week and were physically healthy. Overall mortality rate of mice was
2%. Cervical dislocation was used for euthanasia.
For genotyping of EGFP-Nephrin mice, genomic DNA extracted from tail was amplified
with Thunderbird Probe qPCR Mix (Toyobo, Osaka, Japan) and analyzed by StepOnePlus
Real-Time PCR System (Thermo Fisher Scientific, Waltham, MA, USA). Quantitation was car-
ried out by ΔΔCT method. Amount of EGFP DNA was normalized by that ofMafb DNA
(which has no introns) as internal control. PCR primers and probes used are shown in Table 1.
Reverse transcription-PCR for gene expression analysis
Total RNA was extracted from samples using RNeasy Plus Mini Kit (Qiagen, Hilden, Ger-
many) and cDNA was synthesized by ReverTra Ace qPCR RTMaster Mix with gDNA
Remover (Toyobo, Osaka, Japan). Gene expression levels of nephrin (Nphs1) and podocin
(Nphs2) were examined by quantitative PCR (qPCR) with Thunderbird Probe qPCR Mix and
StepOnePlus Real-Time PCR System, and normalized by 18S ribosomal RNA levels (Table 1)
[17, 18].
Immunostaining of tissues
Kidney tissue in 1mm thickness was fixed with 4% paraformaldehyde (PFA) at 4°C for 30 min
and incubated at 4°C overnight with 20% sucrose in phosphate-buffered saline (PBS). Next
day, tissues were frozen in Tissue-Tek O.C.T. compound (Sakura Finetek Japan, Tokyo, Japan)
and stored at -80°C until analysis. Frozen tissues were sliced with cryostat (CM1950, Leica Bio-
systems, Wetzlar, Germany) at 4 μm thickness. For immunofluorescence [17], kidney sections
or cultured tissues were incubated with PBS containing 10% normal donkey serum (Dako, Agi-
lent Technologies, Santa Clara, CA, USA) and 0.3% Triton X-100 for 30 min, washed and
Fig 1. Schematic diagram of pronuclear injection-based targeted transgenesis (PITT). The donor
vector is co-injected with Cre expression plasmid into the pronuclei of fertilized eggs obtained from seed
mice. As a result of site-specific recombination between mutant loxPs (lox2272, JTZ17 and JT15) by Cre
enzyme, one copy of the donor vector is integrated into Rosa26 genomic locus to yield recombination
intermediate mice. Extra sequence containing selection marker (Neo) and vector sequence is removed by
flippase (FLP)–FLP recombinase target (FRT) gene rearrangement, resulting in generation of Nephrin-EGFP
mice. Nephrin, nephrin promoter sequence; EGFP, EGFP cDNA; pA, poly A signal; Neo, neomycin
resistance gene cassette; FLPe, FLPe-overexpressing deleter mouse.
doi:10.1371/journal.pone.0157497.g001
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incubated with primary antibodies (1:200 dilution) at 4°C overnight: goat anti-mouse nephrin
(R&D Systems, Minneapolis, MN, USA), rabbit anti-mouse/human podocin (against carboxyl
terminal 17 amino acid polypeptide) [19], rat monoclonal anti-mouse platelet-derived growth
factor receptor β (PDGFRβ; cloneAPB5, BioLegend, San Diego, CA, Japan) and rat monoclonal
anti-mouse platelet endothelial cell adhesion molecule-1 (PECAM-1 or CD31; clone MEC 13.3,
BD Biosciences, Franklin Lakes, NJ, USA). Primary antibodies were detected with Alexa Fluor
568-conjugated secondary antibodies (1:200, room temperature for 60 min; Thermo Fisher Sci-
entific) and mounted with Vectashield (Vector Laboratories, Burlingame, CA, USA). Plane and
fluorescence pictures were taken by All-in-One microscopy (BZ-X710, Keyence, Itasca, IL, USA).
For immunohistochemistry of EGFP, kidney tissues were fixed in 4% PFA at 4°C overnight
and embedded in paraffin. Renal sections of 2 μmwere deparaffined, incubated in 0.3% hydro-
gen peroxide/methanol for 15 minutes, hydrated, and incubated with 0.1% trypsin at 37°C for
10 minutes. After rinsing in PBS, sections were incubated with 10% normal goat serum, fol-
lowed by rabbit polyclonal anti-GFP antibody, which recognizes EGFP (1:500, MBL 598,
MBL). Primary antibody was visualized with biotin-conjugated goat anti-rabbit IgG (1:200,
Jackson ImmunoResearch), Vectastain Elite ABC kit (Vector) and 3,3-diaminobenzidine tetra-
hydrochloride (Dako). Nuclei were counterstained with methyl blue.
Isolation and primary culture of glomeruli
Glomeruli were isolated from 8–20 week-old C57BL/6J or Nephrin-EGFP mice using magnetic
beads as described [20]. Under sodium pentobarbital anesthesia (Somnopentyl, Kyoritsu
Seiyaku, Tokyo, Japan), Dynabeads M-450 Tosylactivated (8 x 107, Thermo Fisher Scientific)
dissolved in 30 ml of Hanks’ balanced salt solution (HBSS) were injected through the left ven-
tricle. The kidneys were removed, minced, and digested in HBSS containing collagenase A (1
mg/ml, Roche Diagnostics, Penzberg, Germany) and deoxyribonuclease I (100 U/ml, Roche
Diagnostics) at 37°C for 30 minutes with agitation at 120 rpm. Digested tissue was passed
through 100 μm cell strainer (Falcon, Corning, NY, USA), and glomeruli were collected by

















Probes (P) were modiﬁed by FAM and TAMRA at 5’ and 3’ ends, respectively. F, forward primer. R, reverse primer.
doi:10.1371/journal.pone.0157497.t001
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magnetic stand (Thermo Fisher Scientific) and washed three times with PBS containing 1%
globulin-free bovine serum albumin.
Isolated glomeruli were seeded on 96-well optical plates (Thermo Fisher Scientific) coated
with rat type I collagen (0.3 mg/ml, Corning) at a density of 100–150 glomeruli per well (day 0)
in Dulbecco's Modified Eagle's Medium (with 4.5 g/l glucose, DMEM) containing 10% fetal
bovine serum (FBS, Gibco, Thermo Fisher Scientific) unless otherwise described, and incu-
bated at 37°C with 5% CO2 without passage. After 3 days (on day 3), medium was changed to
DMEM containing 0.5% FBS, and 1α,25-(OH)2 vitamin D3 (Cayman Chemical, Ann Arbor,
MI, USA), all trans-retinoic acid (Sigma, St. Louis, MO, USA), screening compound or vehicle
was added. Cultivation was continued for 2 more days.
Chemical library screening
Pharmacologically active compound libraries were obtained from Prestwick Chemical (Ill-
kirch-Graffenstaden, France), Calbiochem (Merck Millipore, Darmstadt, Germany) and Sell-
eck Chemicals (Houston, TX, USA) through Medical Research Support Center, Graduate
School of Medicine, Kyoto University. Stock solutions (10 mM) were prepared in 100%
dimethly sulfoxide (DMSO) and were arrayed in 96 well plates. Chemical stocks were first
diluted 1:10 with DMSO and further 1:20 with DMEM containing 0.5% FBS. Diluted chemicals
(40 μl) were added into wells (160 μl) containing glomerular tissues to give final concentrations
of 10 μM chemical, 1% DMSO and 0.5% FBS.
Quantitative assay of fluorescence
After cultivation, primary culture of glomerular tissue was fixed with 4% PFA at 4°C for 30
min and stained by immunofluorescence, if appropriate, and also stained with 4',6-diamidino-
2-phenylindole (DAPI, 500 ng/ml, Dojindo, Kumamoto, Japan). Fluorescence intensities of tis-
sues immersed in 100 μl PBS were measured by ArrayScan VTI HCS Reader (Thermo Fisher
Scientific) as described previously [21] using 5x objective (numerical aperture 0.25) through 3
channels: channel 1 (BGRFR 386–23 for DAPI), channel 2 (485–20 for EGFP) and channel 3
(549–15 for Alexa Fluor 568). Images were analyzed by HCS Studio 2.0 Cell Analysis Software
with Cell Health Profiling Algorithm (Thermo Fisher Scientific). Glomeruli were identified as
clusters of DAPI signals whose sizes were larger than a threshold value described in the Result
section. Regions of interest (ROI) were set to glomeruli and signals of respective glomeruli at
channel 2 or 3 were recorded. Data from 4 fields covering majority of a single well were com-
bined and the mean value among glomeruli of each well was calculated.
Statistical analysis
Results are expressed as mean±SEM. Data were analyzed by 2-tailed Student’s t test or
ANOVA. Statistical significance was defined as P<0.05.
Results
Generation of nephrin reporter mice using PITT method
A 5.5 kb nephrin promoter sequence has been shown to target gene expression specifically into
podocytes of Tg mice [15], and nephrin-Cre mice have been successfully used to make podo-
cyte-specific conditional knockout animals [22, 23]. A donor vector carrying Nephrin+EGFP
expression cassette and a Cre expression vector were co-injected into fertilized eggs isolated
from the seed mice to obtain knockin mice carrying a single copy of Nephrin+EGFP cassette at
the Rosa26 locus in the opposite direction to Rosa26 transcription[13, 14] (Fig 1). Of 53 pups
Screening of Nephrin Reporter Glomeruli
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obtained, two mice showed expected gene recombination at the Rosa26 locus in their tail DNA.
These two lines were mated with FLPe mice to remove extra sequence [16] and EGFP expres-
sion was confirmed in both lines preferentially at the periphery of glomeruli by immunohis-
tochemistry (Fig 2A). Line 1 was named Nephrin-EGFP mice, and further analyzed. By
genomic qPCR, wild-type, heterozygous and homozygous Nephrin-EGFP mice could be dis-
tinguished (Fig 2B). Heterozygotes were used to study regulation of EGFP expression.
Renal localization of EGFP expression
By immunofluorescence, EGFP expression co-localized well with endogenous nephrin and
podocin, which are podocyte-specific molecules (Fig 3). On the other hand, cells stained by
antibodies against PDGFR β (mesangial cell marker) or PECAM-1 (endothelial cell marker)
did not express EGFP. Outside of glomeruli, no EGFP expression was observed. These findings
verified that EGFP was specifically expressed in podocytes of Nephrin-EGFP mice.
Cultivation of glomeruli from Nephrin-EGFPmice
By magnetic bead method, approximately 10,000–20,000 glomeruli were obtained per mouse
(95% purity by light microscopy) as previously described [20]. When glomeruli from Nephrin-
EGFP mice were cultivated, EGFP fluorescence persisted at least for 2 days on the surface of
glomeruli, but was markedly reduced within 5 days (Fig 4). On the other hand, after 1 or 2
days, nephrinmRNA level was decreased to 4.9% of the initial level on day1, further decreased
to 0.8% on day 2, and partially recovered to 14.9% on day 5 (Fig 5). Apparent difference in the
time course between EGFP fluorescence and nephrinmRNA was likely caused by much longer
half life of EGFP molecule compared to that of endogenous nephrinmRNA. PodocinmRNA of
cultured glomeruli showed similar changes: 1.8%, 0.9% and 17.6% on days 1, 2 and 5, respec-
tively (Fig 5).
Previous reports showed that nephrin expression in cultured podocytes or renal precursor
cells was increased by treatment with 10–100 nM vitamin D and 1 μM retinoic acid [6–8]. In
glomeruli from Nephrin-EGFP mice, addition of vitamin D+retinoic acid increased EGFP fluo-
rescence (Fig 4), thus validating our reporter system.
Automated quantitation of EGFP signals
To detect glomeruli, cultivated material was fixed and stained with a nuclear marker DAPI.
Blue signals by DAPI were scattered in podocyte outgrowth, but were clustered in glomeruli
Fig 2. EGFP expression and genotyping of Nephrin-EGFPmice. (A) EGFP protein was expressed preferentially at
periphery of glomeruli in two lines of Nephrin-EGFPmice by immunohistochemistry using anti-GFP antibody. (B) Genotyping
of wild-type (WT), heterozygous (Hetero) and homozygous (Homo) mice by genomic qPCR. Amount of EGFP genomic DNA
detected in WTmice was less than 1% of heterozygous mice. Mean±SEM of n = 4–8. Comparison was carried out by
unpaired t test. Magnification, 10x.
doi:10.1371/journal.pone.0157497.g002
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(Fig 6A). The sizes of DAPI clusters were automatically calculated. When a threshold
of> 2000 μm2 was selected, recognition of glomeruli from migrated podocytes was best per-
formed and matched well with visual judgement (Fig 6B). This threshold seems reasonable
since it is consistent to a diameter of> 45 μm used in classical sieving method for mouse glo-
merulus isolation [24]. After setting ROI to glomerular areas, EGFP signals in glomeruli were
quantitated as green fluorescence (Fig 6C).
After 5 days of culture, some glomeruli showed preserved structure, while other glomeruli
appeared destructed or melted by escape of cells from glomeruli (Fig 6A). As a consequence,
total EGFP signals (Fig 7A) and the numbers of DAPI-positive cells (Fig 6A) of individual glo-
meruli were highly variable even in a single well. Consistently, when EGFP signal per DAPI sig-
nal was calculated for each glomerulus, distribution of histogram was much concentrated (Fig
7B). When normalization of EGFP signal by area and that by DAPI signal were compared, they
gave very similar patterns (Fig 7C and 7D). Therefore, simple normalization by area was
Fig 3. Protein expression of EGFP and glomerular cell markers in Nephrin-EGFPmice. (A-C) EGFP and nephrin were
co-expressed along glomerular capillaries (yellow arrowheads). Cell bodies of podocytes located at the outer surface of
glomerular capillaries (green arrowheads) also expressed EGFP (A) but nephrin expression was spared (B). (D) Similarly,
EGFP and podocin were expressed along glomerular capillaries (yellow arrowheads). Podocyte cell bodies expressed EGFP
but not podocin (green arrowheads). (E) PDGFRβwas expressed at glomerular and peritubular capillaries (arrowheads) and
walls of arterioles (arrows), and did not co-localize with EGFP. (F) PECAM-1 was expressed along glomerular and peritubular
capillaries (arrowheads) and inner surface of arterioles (arrow), and did not merge with EGFP. Magnification, 40x.
doi:10.1371/journal.pone.0157497.g003
Fig 4. EGFP expression in cultured glomeruli from Nephrin-EGFPmice.On Day 2, EGFP expression remained mainly
along the periphery of glomeruli, but was markedly reduced on day 5. FBS concentration was reduced from 10% to 0.5% on
day 3. Treatment with 1α,25-(OH)2 vitamin D3 (VD, 50 nM) and all trans-retinoic acid (RA, 1 μM) for the last 2 days induced
EGFP expression. Veh, vehicle. Magnification, 10x.
doi:10.1371/journal.pone.0157497.g004
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chosen, and the average of EGFP signal/glomerular area among whole glomeruli from each
well was used as a representative value for that well.
Next, FBS concentration for chemical screening was optimized (Fig 8). After isolation from
Nephrin-EGFP mice, glomeruli were seeded at a density of 100–150 glomeruli per well and cul-
tivated for 3 days in DMEM containing 0%, 0.5% or 10% FBS (Days 0–3). By changing medium
to fresh DMEM with 0%, 0.5% or 5% FBS on day 3, approximately half of glomeruli were
removed. On day 5, cultured materials were fixed and stained with DAPI. At this point,
approximately one third of glomeruli of the initial number were retained on plates (with some
variations) and EGFP fluorescence was quantitated. Culturing glomeruli with 10% FBS for the
first 3 days (days 0–3) increased the recovery of glomeruli by 30% compared to 0% or 0.5%
FBS (Fig 8A). Cultivation with 5% FBS during the last 2 days (days 4–5, in the presence of vita-
min D plus retinoic acid) further increased recovery by 20% compared to 0% or 0.5% FBS dur-
ing days 4–5. When EGFP signals were measured as EGFP/Area, cultivation with 5% FBS
during days 4–5 reduced the signals by 20% compared to 0.5% FBS during days 4–5 (after incu-
bation with 0.5% or 10% FBS during days 0–3), presumably due to enhanced outgrowth and
escape of podocytes from glomeruli by 5% FBS during days 4–5 (Fig 8B). As a consequence,
Fig 5. Expression of nephrin and podocinmRNA in cultured glomeruli.Gene expression was studied on
days 0–5 (D0-D5) and at 6 hours (6h). Vitamin D (VD, 50 nM) or vehicle (Veh) was added for the last two
days. Expression levels were normalized by 18S ribosomal RNA and levels at D0 were defined as 100%.
Mean±SEM of n = 5. Treatment with VD significantly upregulated nephrin expression by unpaired t test. NS,
not significant. *P<0.001 vs D0 by one-way ANOVAwith Dunnett’s post hoc test.
doi:10.1371/journal.pone.0157497.g005
Fig 6. Quantitative evaluation of EGFP signals in glomerular areas. (A) Glomeruli appeared as clusters
of DAPI signals. (B) DAPI clusters having areas larger than > 2000 μm2 were recognized as glomeruli and
ROI were set to such glomerular areas (yellow arrows), whereas smaller clusters were excluded from ROI
(green arrows). (C) EGFP signals were measured only in ROI. Magnification, 10x.
doi:10.1371/journal.pone.0157497.g006
Screening of Nephrin Reporter Glomeruli
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10% FBS on days 0–3 plus 0.5% FBS on days 4–5 gave the largest difference between vitamin
D+retinoic acid vs vehicle treatment in EGFP/Area values (by more than 2-fold, Fig 8C), and
these FBS conditions were selected.
Fig 7. Histogram of EGFP signals of respective glomeruli. (A) In a single well, total EGFP signal of each glomerulus was calculated individually, and
fractionated as histogram. (B) EGFP signal per DAPI signal was calculated and analyzed. (C) Each bar indicates mean±SEM of EGFP/Area among several
dozens of glomeruli from a single well (Fig 8A). Vitamin D+retinoic acid (VD+RA) or vehicle (Veh)-treated glomeruli were studied in triplicate wells. (D) Each
bar indicates mean±SEM of EGFP/DAPI of a well.
doi:10.1371/journal.pone.0157497.g007
Fig 8. Effects of FBS upon EGFP signals.Glomeruli from Nephrin-EGFPmice were cultivated for the first 3
days (D0-D3) and the last 2 days (D4-D5) with DMEM containing different concentrations of FBS and
fluorescence was examined on D5. Vitamin D (50 nM, VD)+retinoic acid (1 μM, RA) or vehicle (Veh) was
added during D4-D5. (A) Glomerular count per well of glomeruli given VD+RA during D4-D5. Mean±SEM of
n = 3. (B) EGFP signal per glomerular area. N = 3. (C) Effects of VD+RA upon EGFP/Area signals. The
average value from wells treated with VD+RAwas divided by the average value from Veh-treated wells.
doi:10.1371/journal.pone.0157497.g008
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Performance of Nephrin-EGFP mouse glomeruli in culture system
First, the effects of various vitamin D concentrations were tested. EGFP signals were dose-
dependently increased by vitamin D: 2.6-fold by 1 nM, 3.9-fold by 50 nM and 4.5-fold by 1250
nM (Fig 9). Since addition of retinoic acid (1 μM) to 50 nM vitamin D did not further increase
expression of EGFP, we chose 50 nM vitamin D without retinoic acid as a positive control for
glomerular EGFP assay. Treatment of glomeruli during the last two days with vitamin D in the
presence of 0.5% FBS increased nephrinmRNA expression by 3.6-fold on day 5 compared to
vehicle treatment, without significant effects upon podocinmRNA (Fig 5). Dose-response
curves of EGFP signals and nephrinmRNA expression by vitamin D were considerably propor-
tional (Fig 9).
We studied effects of DMSO upon chemical screening, since all reagents were first dissolved
in DMSO. DMSO at 2% mildly decreased EGFP signals both in vehicle- and 50 nM vitamin D-
treated glomeruli by 20% (Fig 10), but 1% DMSO showed no significant effects. Therefore, we
judged that presence of 0.1–1% DMSO during screening is tolerable.
Endogenous nephrin protein expression in cultured glomeruli and its change by vitamin D
was examined. By immunofluorescence and quantitation, nephrin protein expression was
increased by 2.7-fold with vitamin D treatment, while EGFP signal was increased by 4.1-fold (Fig
11). On the other hand, podocin protein expression was only mildly increased (1.3-fold) by vita-
min D, suggesting predominant effects of vitamin D upon nephrin expression. In a time course
analysis, EGFP intensity was slightly elevated on day 2, and gradually decreased towards day 5.
An example of screening in a 96-well format is shown in Fig 12. Vitamin D-treated wells
showed constantly and clearly increased EGFP fluorescence signals by excitation compared to
Fig 9. Dose-dependent induction of EGFP signals and nephrinmRNA expression by vitamin D.
Cultured glomeruli from Nephrin-EGFPmice were treated with 1–1250 nM of vitamin D (VD), 1 μM retinoic
acid (RA) or vehicle (0 nM) for the last 2 days and analyzed on day 5. (A) EGFP/glomerular area. Mean
background signal of wild-type glomeruli was subtracted. (B) NephrinmRNA expression. Expression levels
were normalized by 18S ribosomal RNA. Each bar indicate mean±SEM of triplicate wells. The level of vehicle
was defined as 1.0 unit. #P<0.001 or *P<0.05 vs vehicle by one-way ANOVA with Bonferroni’s multiple
comparison test.
doi:10.1371/journal.pone.0157497.g009
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vehicle-treated wells (Fig 12). Positive wells with similar signal levels or much stronger signals
compared to vitamin D-treated wells were also found. Next, we investigated dose-response of
some positive chemicals as to EGFP intensity (Fig 13). Very strong EGFP signals by several
reagents were often reduced by 90% when the reagent concentrations were reduced by 90%,
which was not the case with vitamin D (Fig 9). We realized that, in such cases, chemicals pre-
sumably gave very strong fluorescence in glomeruli because of the colors of reagents (which are
visible even under standard room light, Fig 13), especially when they had high cell permeability
to live cells. These findings suggested that studying dose-response and the color of compounds
may be efficient ways to exclude false positive hits from the primary screening.
Discussion
In the present study, we generated Nephrin-EGFP mice, which specifically express EGFP in
podocytes under the control of nephrin promoter inserted at the Rosa26 locus. To our
Fig 10. Effects of DMSO upon EGFP signals. Vitamin D (VD) or DMSOwas added for the last 2 days and
fluorescence was examined as EGFP/glomerular area on day 5. Mean±SEM of n = 3. Addition of 2% DMSO
significantly decreased EGFP signals both in vehicle- and VD-treated glomeruli (P<0.05). Treatment with VD
significantly increased EGFP signals in the presence of all concentrations of DMSO studied (0 to 2%,
P<0.001). Comparison was carried out by two-way ANOVA with Bonferroni’s multiple comparison test.
doi:10.1371/journal.pone.0157497.g010
Fig 11. Quantitative evaluation of changes in EGFP, nephrin and podocin protein expression in
glomeruli by vitamin D. Endogenous nephrin and podocin were visualized by immunofluorescence using
primary antibodies and Alexa Fluor 568-conjugated secondary antibodies. Fluorescence intensity was
measured on days 1–5 (D1-D5). Glomeruli were treated with 50 nM vitamin D (VD) or vehicle (Veh) for the
last 2 days and examined on day 5 (D5), and the difference was studied by unpaired t test. For EGFP
quantitation, mean background signal of wild-type glomeruli was subtracted and the level of Veh-treated
Nephrin-EGFP glomeruli on D5 was defined as 1.0 unit. For nephrin and podocin, mean background signal of
wild-type glomeruli incubated with secondary antibody alone was subtracted, respectively. Difference
between EGFP signals among days was examined by one-way ANOVA with Bonferroni’s multiple
comparison test. N = 5.
doi:10.1371/journal.pone.0157497.g011
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knowledge, this strain is the first nephrin reporter line to be established by knockin strategy,
instead of conventional random transgene insertion [25]. Next, we isolated glomeruli from
these mice, and set up cultivation and assay which can be used to screen reagents enhancing
nephrin transcriptional activity.
We previously showed that, unlike traditional random-insertion transgenesis approaches,
the targeted transgenesis approach using PITT (insertion of a gene of interest into the Rosa26
locus) enables to obtain Tg mice with stable, reliable, predictable, and reproducible transgene
Fig 12. An example of chemical library screening of a plate. Y axis indicates EGFP intensity/glomerular
area of each well under excitation. Wells treated with vitamin D (red circles) or vehicle (blue circles) are
highlighted.
doi:10.1371/journal.pone.0157497.g012
Fig 13. Strong and linear effects by auto-fluorescence of chemicals upon screening by EGFP signal intensity. (A) Cat#,
catalog number. a, Pairs of compound concentrations with linear dose-response (10-times more compound giving approximately
10-times more signal), which suggest non-specific effects reflecting compound colors. b, Glomeruli treated with 10 μM of Ro-31-
8220 were detached from plate likely due to drug toxicity. c, 10 nM Vitamin D and 1%DMSO served as positive and negative
controls for EGFP/glomerular area signals under excitation. Background subtraction of signal by wild-type glomeruli was not
carried out here. (B) Photograph of chemical compound stock solution (1 mM) under standard room light, showing intrinsic colors
in some solutions.
doi:10.1371/journal.pone.0157497.g013
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expression when constitutive CAG promoter was used [13, 14]. In the present study, we
applied the PITT strategy for generation of Tg mice showing tissue-specific expression. Because
both of two Nephrin-EGFP founder mouse lines identically exhibited highly podocyte-specific
expression, the PITT method is useful also for production of tissue-specific Tg mice with
reproducible and expected transgene expression.
Since podocytes play an essential role for maintenance of structure and function of glomer-
uli [1–5], cultured podocytes have been successfully used to screen chemicals possessing activi-
ties to prevent morphological change or damage of podocytes [26]. Upon cultivation of
glomeruli on plates covered with type I collagen, podocytes start to migrate out as single cells
[27] but substantial amount of podocytes remain upon glomeruli. For assessment of EGFP
expression, we uniquely focused on podocytes attached to glomeruli, since such cells are ligated
to a native scaffold, glomerular basement membrane, and located close to endogenous mesan-
gial and endothelial cells, which might help mutual exchange of soluble factors such as vascular
endothelial growth factor [25].
Our system is also unique in a point that we used freshly isolated glomeruli and podocytes
without any passage. Since podocytes are terminally differentiated cells with very small prolif-
erating capacity especially in vivo [28], primary podocytes cannot keep on growing and require
immortalization procedure for propagation [29], which might alter the nature of podocytes.
Further studies are required to judge whether features in our screening method provides
advantage compared to methods reported so far [6, 10, 26].
There are several limitations in this work. In our culture system, certain number of podocytes
are lost by day 5 (when EGFP intensity is evaluated) by podocyte outgrowth and medium change.
Furthermore, we describe here that colors of the original compounds may affect the results of fluo-
rescence-based assay. Therefore, findings in nephrin reporter assay have to be verified by evaluation
of endogenous nephrin mRNA and protein expression as we did for vitamin D (Figs 5 and 11).
Vitamin D has been known to upregulate nephrin expression both in vitro and vivo, and to
inhibit glomerular injury [6, 9–11]. Using Nephrin-EGFP glomeruli, we could show that vita-
min D increases EGFP fluorescence intensity as a positive control essential for chemical library
screening.
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